Evaluation Of Deep Anterior Lamellar Keratoplasty By Anterior Segment Ocular Coherence Tomography

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05345652
Collaborator
(none)
20
29

Study Details

Study Description

Brief Summary

Investigators' research is concerned observing the post-operative anterior segment OCT changes throughout the post- operative follow up of the patient and relating to improve the visual outcome of the surgery which is the goal of surgery

Condition or Disease Intervention/Treatment Phase
  • Procedure: deep anterior lamellar keratoplasty

Detailed Description

Study tools (in detail, e.g., lab methods, instruments, steps, chemicals, …):
  • Complete medical and ocular history, including patients' age, sex, type of pathology of the cornea such as keratoconus, opacity , history of previous corneal intervention , and other ocular surgeries.

  • Thorough ophthalmological examination, including visual acuity, intraocular pressure (IOP) measuring by Goldman applanation tonometer (Haag Streit, Koeniz, Switzerland), slit lamp biomicroscopic examination of anterior segment, investigations for keratoconus as pentacam , preoperative anterior segment OCT if needed , slit lamp photography for the cornea .

Candidate patients will be operated through DALK , then will be examined post operative clinically and be followed up at 3 months , 6 months for best corrected visual acuity, Intraocular pressure , refraction , graft healing , and anterior segment OCT for the anterior chamber angel , graft healing , descemet's membrane state , tear film . The interpretation of the clinical data with the changes in the ant. Segment OCT will give us the clue to get the best visual outcome of surgery .

2.4.5 -Research outcome measures:

  1. Primary (main):

To evaluate the post-operative changes after DALK surgery through ant segment OCT and its relation to clinical findings.

  1. Secondary (subsidiary): To improve the outcome of the surgery through the graft creation , stitching of the graft , following up the IOP clinically and state of AC angel through OCT , the tear film and changes after surgery , all these factors to improve the target of the surgery which is the post operative best corrected visual acuity .

Data collection Data to be collected include patients' age, sex, cause of corneal surgery ,BCVA, IOP levels, clinical examination of the eye and if there are findings , and ant. Segment OCT of the eye Computer software Data analysis will be done via SPSS version 26 windows 10 Statistical tests Data will be statistically described in terms of mean, SD, and range when appropriate. Comparisons between the preoperative and postoperative data will be done using Student's t-test. Study groups' comparisons will be done using Student's t-test for independent normally distributed samples data.

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation Of Deep Anterior Lamellar Keratoplasty By Anterior Segment Ocular Coherence Tomography
Anticipated Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Mar 29, 2024
Anticipated Study Completion Date :
Sep 29, 2024

Outcome Measures

Primary Outcome Measures

  1. To evaluate the post-operative changes after DALK surgery through ant segment OCT and its relation to clinical findings. [6 months after the surgery]

    To evaluate the post-operative changes after DALK surgery through ant segment OCT and its relation to clinical findings.

Secondary Outcome Measures

  1. To Improve sugery [6 months after the surgery]

    To improve the post operative best corrected visual acuity .

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing DALK surgery older than 18 years old ( keratoconus and corneal opacity ).
Exclusion Criteria:
  • Patients suffering from active corneal ulcer

  • Active infection.

  • Posterior segment diseases.

  • Recent ocular surgery in the study eye in the 2 months prior to enrolment,

  • Media opacities as vitreous haemorrhage,

  • Vasculitis , patients with macular edema related to, glaucoma, chronic uveitis, or pre-existing ocular pathologic features or abnormalities.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

  • Study Director: momen A Mohammad, Lecturer, Assiut University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ali Omar Mohamed Ali, Principal Investigator, Assiut University
ClinicalTrials.gov Identifier:
NCT05345652
Other Study ID Numbers:
  • Ant. segment OCT in DALK
First Posted:
Apr 26, 2022
Last Update Posted:
Apr 26, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 26, 2022